Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Pfizer a Smart Coronavirus Stock to Buy After Moderna's Great Vaccine Results?

TheMotleyFool

0 0

Is Pfizer a Smart Coronavirus Stock to Buy After Moderna's Great Vaccine Results?

The euphoria surrounding last week's news about tremendous efficacy results for the experimental coronavirus vaccine developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) didn't last long. On Monday, Moderna (NASDAQ: MRNA) upped the ante with even better results for its COVID-19 vaccine candidate, mRNA-1273.

Unsurprisingly, Pfizer stock slipped on Moderna's positive report. Is the big pharma still a smart coronavirus stock to buy after Moderna's great vaccine news?

Image source: Getty Images.

Source Fool.com

Like: 0

PFE

Share